A Study of Mirikizumab in Participants With Plaque Psoriasis
Status:
Completed
Trial end date:
2019-10-28
Target enrollment:
Participant gender:
Summary
This study is known as a "drug interaction study." The purpose is to learn how commonly used
drugs or substances (midazolam, warfarin, dextromethorphan, omeprazole, and caffeine) and
their breakdown products get into the bloodstream after taking a "cocktail" (combination) of
them before and after multiple doses of mirikizumab.
The study will last about 23 weeks for each participant. Screening must be completed within 4
weeks prior to study start.